Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Journal for Immunotherapy of Cancer
|
May 19, 2018
Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis
Michael Lattanzi, Joseph Han, Una Moran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2015
A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis
Doug Hanniford, Judy Zhong, Lisa Koetz, et al.
American Journal of Surgery
|
August 16, 2016
Use of the surgical Apgar score to enhance Veterans Affairs Surgical Quality Improvement Program surgical risk assessment in veterans undergoing major intra-abdominal surgery
Antonio Masi, Salvatore Amodeo, Ioannis Hatzaras, et al.
Journal of Translational Medicine
|
November 6, 2013
Melanoma risk loci as determinants of melanoma recurrence and survival
Justin Rendleman, Shulian Shang, Christine Dominianni, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 17, 2009
Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival
Dusan Bogunovic, David W O'Neill, Ilana Belitskaya-Levy, et al.
Journal of Medical Genetics
|
January 22, 2015
Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma
Justin Rendleman, Matjaz Vogelsang, Anuj Bapodra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2009
Association of MDM2 SNP309, age of onset, and gender in cutaneous melanoma
Elnaz F Firoz, Melanie Warycha, Jan Zakrzewski, et al.
Cancer Immunity
|
July 13, 2007
Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factors
Elsa F Velazquez, Achim A Jungbluth, Molly Yancovitz, et al.
The Journal of Investigative Dermatology
|
February 23, 2020
TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma Tumors
Gregory A Chang, Jennifer M Wiggins, Broderick C Corless, et al.
Journal of the National Cancer Institute
|
June 19, 2018
Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy
Michael Lattanzi, Yesung Lee, Danny Simpson, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Journal for Immunotherapy of Cancer
|
May 19, 2018
Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis
Michael Lattanzi, Joseph Han, Una Moran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2015
A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis
Doug Hanniford, Judy Zhong, Lisa Koetz, et al.
American Journal of Surgery
|
August 16, 2016
Use of the surgical Apgar score to enhance Veterans Affairs Surgical Quality Improvement Program surgical risk assessment in veterans undergoing major intra-abdominal surgery
Antonio Masi, Salvatore Amodeo, Ioannis Hatzaras, et al.
Journal of Translational Medicine
|
November 6, 2013
Melanoma risk loci as determinants of melanoma recurrence and survival
Justin Rendleman, Shulian Shang, Christine Dominianni, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 17, 2009
Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival
Dusan Bogunovic, David W O'Neill, Ilana Belitskaya-Levy, et al.
Journal of Medical Genetics
|
January 22, 2015
Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma
Justin Rendleman, Matjaz Vogelsang, Anuj Bapodra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2009
Association of MDM2 SNP309, age of onset, and gender in cutaneous melanoma
Elnaz F Firoz, Melanie Warycha, Jan Zakrzewski, et al.
Cancer Immunity
|
July 13, 2007
Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factors
Elsa F Velazquez, Achim A Jungbluth, Molly Yancovitz, et al.
The Journal of Investigative Dermatology
|
February 23, 2020
TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma Tumors
Gregory A Chang, Jennifer M Wiggins, Broderick C Corless, et al.
Journal of the National Cancer Institute
|
June 19, 2018
Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy
Michael Lattanzi, Yesung Lee, Danny Simpson, et al.
Page
of 4